A study into the practice of using long acting insulin in type 2's

[Amity Island]

Little is known about the prescription of expensive non-recommended newer long-acting insulins (glargine 300 U/ml and degludec) for type 2 diabetes mellitus (T2DM) patients. Aim To identify practice variation in and practice and patient-related characteristics associated with the prescription of newer long-acting insulins to T2DM patients in primary care.

Newer long-acting insulin prescriptions for patients with type 2 diabetes: prevalence and practice variation in a retrospective cohort study

Background Little is known about prescription patterns of expensive non-recommended newer long-acting insulins (glargine 300 U/mL and degludec) for patients with type 2 diabetes mellitus (T2DM). Aim To identify practice variation in, and practice- and patient-related characteristics associated...

bjgp.org